COVID-19 had stormed through the world in early March of 2019, and on 5 May 2023, SARS-
CoV-2 was officially declared to no longer be a global health emergency. The rise of new …

As the world transitions from the acute phase of the COVID-19 pandemic, a novel concern
has arisen—interstitial lung disease (ILD) as a consequence of SARS-CoV-2 infection. This …

Background Studies have established the short-term efficacy of nirmatrelvir–ritonavir in
managing COVID-19, yet its effect on post-COVID-19 condition, especially in patients …

Objective: The most common symptom of post-acute coronavirus disease 2019 (COVID-19)
is fatigue, and it potentially leads to myalgic encephalomyelitis/chronic fatigue syndrome …

Objectives Studies have reported increased rates of long-term neuropsychiatric sequelae
after SARS-CoV-2 infection using electronic health-record (EHR) data; however, the majority …

The persisting risk of long-term health consequences of SARS-CoV-2 infection and the
protection against such risk conferred by COVID-19 vaccination remains unclear. Here we …

Summary Background Characterizing Post-Acute Sequelae of COVID (SARS-CoV-2
Infection), or PASC has been challenging due to the multitude of sub-phenotypes, temporal …

The ongoing COVID-19 pandemic has profoundly affected millions of lives globally, with
some individuals experiencing persistent symptoms even after recovering. Understanding …

Coronavirus disease 2019 (COVID-19) is a respiratory tract infection caused by severe
acute respiratory syndrome coronavirus 2 that can have detrimental effects on multiple …

COVID-19 has generated a scenario for global health with multiple systemic impairments.
This retrospective study evaluated the clinical, radiological, and pulmonary functional …